IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.
about
Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cellsIncreased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsiesS100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expressionReactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells.Loss of SIMPL compromises TNF-alpha-dependent survival of hematopoietic progenitors.NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL.Molecular events in bronchogenic carcinoma and their implications for therapy.Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity.Gene therapy in lung cancer.An NAD(P)H oxidase regulates growth and transcription in melanoma cells.S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and releaseThe role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis.Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta.Gene therapy for lung cancer
P2860
Q24810732-7B629A5B-55D1-4AB6-95D2-11C47AC550E4Q25257717-62748233-4912-4CE6-84E8-A96437F90673Q28566688-E31CD6B1-0C12-4DEC-91AF-3FD792B71199Q31919510-7C4EF2EA-32E5-4EDB-B409-A9B876C9BD5AQ33625589-0E9BFAA8-A3B9-46B8-B073-998B8F3A3B85Q33729242-2D6F68F9-AEB5-4179-A5B1-AD31D0BAA5D7Q33829241-445D75D7-4BFF-46FB-A4CF-8DF16292131EQ33925065-6A88C919-A78A-4455-B9BA-7A26BE361166Q34107787-1D857A9E-B1F7-4015-86CF-7C2B5C092A45Q34127326-B727A636-3C00-4975-9834-A9815F126B41Q34606206-8881A396-3EF1-4273-9282-4CC59DDD3905Q35627680-D5CDDA78-E6FC-4227-A271-A4940B17E3ACQ36276848-64B326AF-86EE-4CA3-AD8F-000A878EA371Q37101017-8B65C476-D728-4474-B2B8-D9FCBFD216B1Q40391803-DBFE096B-E802-4589-9A28-50DD1A0D95CDQ40799697-510597FC-1C6F-480A-9536-D4BAB5EB2CC0Q58409685-C4174018-EF09-4539-A6B0-A09163795D7F
P2860
IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
IkappaBalpha gene transfer is ...... tor-alpha-mediated cell death.
@en
type
label
IkappaBalpha gene transfer is ...... tor-alpha-mediated cell death.
@en
prefLabel
IkappaBalpha gene transfer is ...... tor-alpha-mediated cell death.
@en
P2093
P2860
P356
P1476
IkappaBalpha gene transfer is ...... ctor-alpha-mediated cell death
@en
P2093
A S Baldwin
D A Brenner
D C Guttridge
R C Boucher
S M Dubinett
P2860
P304
P356
10.1165/AJRCMB.21.2.3470
P50
P577
1999-08-01T00:00:00Z